Added calcium and phosphate in fluoride varnishes no silver bullet for fighting kids’ tooth decay, study finds

Ver­tex has paused the Phase I/II study of its islet cell ther­a­py for type 1 di­a­betes fol­low­ing the death of two pa­tients, though the com­pa­ny

More debate about whether the lowest-risk prostate cancers should even be called “cancer.” (Harvard Health Publishing) Four cancer drugs — palbociclib (Ibrance), enzalutamide (Xtandi), pomalidomide

Af­ter a se­ries of bru­tal set­backs that have chopped Bay­er’s mar­ket val­ue by around 21% in the last month, the Ger­man drug­mak­er un­veiled an over­hauled